Nattokinase Market

The market for nattokinase is estimated at USD XX billion in 2024; it is projected to grow at a CAGR of XX% to reach USD XX billion by 2029. Nattokinase (NK), a natural fibrinolytic enzyme derived from Bacillus-fermented soybeans like natto, is gaining increasing attention for its potential to support cardiovascular health. With the rising global prevalence of cardiovascular diseases (CVDs), particularly those caused by thrombus formation, NK is seen as a promising alternative to traditional thrombolytic drugs. This interest is fueled by NK’s multiple mechanisms of action, including direct fibrin degradation and promotion of plasminogen activation, which contribute to its potent thrombolytic effects. Compared to clinical thrombolytic drugs, NK offers advantages such as high activity, rapid and prolonged effects, minimal toxicity, and a lower production cost, making it an attractive option for prevention and treatment of CVDs. (Source: NCBI)

The microbial synthesis of NK, predominantly through Bacillus spp., is a cost-effective production method that has seen considerable advancements. Despite challenges in improving NK yield, activity, and stability, ongoing optimization strategies have enabled more efficient production, bringing NK closer to meeting commercial demand. NK is increasingly incorporated into fermented soybean foods, nutraceutical supplements, and even functional foods, all of which are contributing to its rising popularity in health-conscious markets.

The growing consumer awareness of the importance of dietary supplements in preventing chronic conditions, particularly cardiovascular diseases, is driving the demand for NK. As research continues to highlight NK's benefits, including its safety and effectiveness, it is positioned as a natural, preventive option against CVDs, complementing conventional medical treatments. With the continuous exploration of NK’s production techniques and biological functions, the market for nattokinase is poised for rapid growth, especially in regions like North America and Asia, where the demand for natural health solutions is increasing. NK’s potential as an effective, cost-efficient, and safe alternative to traditional cardiovascular treatments is helping expand its presence in the global nutraceutical market.

Global Nattokinase Market Trends

Drivers:

Ongoing studies showing Nattokinase efficiency

The key drivers for the growth of the nattokinase market is the ongoing clinical research evaluating its cardiovascular efficacy. For example, sciencedirect’s a recent systematic review (2023) and meta-analysis of randomized controlled trials (RCTs) explored the effects of nattokinase supplementation on various cardiovascular risk factors. The study, which included six RCTs with 546 participants, highlighted that nattokinase supplementation, particularly at higher doses, significantly reduced systolic and diastolic blood pressure. Additionally, it was found to have a mild effect on blood glucose levels, but no significant adverse events were reported, emphasizing its safety profile.

However, the study also revealed that lower doses of nattokinase had a negative impact on lipid profiles, such as total cholesterol and low-density lipoprotein cholesterol, suggesting that the efficacy of nattokinase in lipid-lowering may be dose-dependent. This finding underscores the importance of ongoing research to further optimize dosages and better understand the broader benefits of nattokinase for cardiovascular health. As such, the increasing body of evidence surrounding nattokinase’s cardiovascular effects is a major driver for its market growth, supporting its use as a potential adjunctive therapy for hypertension and heart health.

Restraints:

Limited consumer knowledge about Nattokinase benefits

Despite the mounting scientific evidence, one of the main barriers to the widespread adoption of nattokinase is limited consumer knowledge about its benefits. While the supplement market has expanded rapidly, nattokinase still remains relatively niche, with many consumers unfamiliar with its health-promoting properties. For instance, while heart disease is a leading cause of death, many people are unaware that natural substances like nattokinase could potentially play a role in prevention or treatment.

To overcome this challenge, extensive educational campaigns are needed to raise awareness about the cardiovascular benefits of nattokinase. As highlighted by initiatives of the Japan NattoKinase Association such as "Thrombus Prevention Month", despite the growing recognition of nattokinase's potential for preventing thrombus formation and supporting cardiovascular health, many people remain unaware of its specific effects or the best ways to incorporate it into their lifestyle. For example, "Thrombus Prevention Day," observed on January 20th, was created to raise awareness of thrombus-related health risks and promote nattokinase as a solution. However, the campaign reveals a significant challenge: while the message is reaching some, there is still a broader gap in consumer knowledge. Many individuals remain unaware of the importance of fibrinolytic activity or how supplements like nattokinase can help prevent blood clots. Additionally, misconceptions around the effects of natto, which contains Vitamin K2 (a blood-clotting agent), further complicate the understanding of how nattokinase, the thrombolytic component of natto, can be beneficial on its own. Until this knowledge barrier is addressed, the market for nattokinase will face limitations in reaching a wider audience.

Opportunities:

Integration of Nattokinase into functional foods and beverages

The integration of nattokinase into functional foods and beverages presents a significant opportunity for market expansion. Functional foods, which provide health benefits beyond basic nutrition, have become increasingly popular among health-conscious consumers, especially in markets like North America and Asia. Nattokinase can be incorporated into everyday food and beverage products, such as smoothies, juices, energy bars, or even teas, offering a convenient way for consumers to benefit from its cardiovascular support without the need to take traditional supplements.

For instance, companies are already exploring ways to add nattokinase to heart-healthy functional foods, catering to individuals seeking to improve their lifestyle and reduce the risk of cardiovascular diseases. This presents an exciting opportunity for both manufacturers and consumers. For manufacturers, it opens up new product categories and revenue streams, while for consumers, it offers an easy and accessible way to add a beneficial enzyme to their daily routine. As demand for functional foods and beverages continues to rise, nattokinase’s inclusion in these products could become a key driver of its market growth.

Challenges:

Addressing doubts about efficacy and safety

While the potential of nattokinase is promising, one of the key challenges remains addressing doubts about its efficacy and safety, particularly among skeptical consumers and healthcare professionals. Some individuals may hesitate to rely on a naturally derived product for managing serious health conditions like heart disease due to the prevalence of conventional treatments, such as pharmaceutical thrombolytics and anticoagulants. Additionally, the lack of large-scale, long-term clinical trials comparing nattokinase directly with conventional medications may fuel these doubts.

Moreover, despite its natural origin, some consumers may question whether nattokinase is truly as effective or safe as more established, scientifically validated treatments. Ensuring that nattokinase products meet rigorous safety standards, backed by transparent and robust clinical research, is essential for overcoming these doubts. Manufacturers must address these concerns through clear communication, scientific studies, and third-party validations that demonstrate nattokinase’s safety profile and its proven health benefits.

Nattokinase Market Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of nattokinase. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include Japan Bio Science Laboratory Co., Ltd. (Japan), Novozymes A/S, Part of Novonesis Group (Denmark), Biocat GmbH (Germany), Bioven Ingredients (India), Eiffel Biotech (Taiwan) among others.

Based on Application, the nutraceuticals segment is projected to be the dominant segment in the market.

The nutraceuticals segment is expected to be the dominant segment in the nattokinase market due to the increasing consumer demand for natural health supplements that support cardiovascular health. Nattokinase, a natural enzyme derived from natto (fermented soybeans), is increasingly popular as a preventive measure for conditions like stroke, deep vein thrombosis (DVT), and heart disease.

With a growing awareness of the importance of heart health and the benefits of using natural, non-pharmaceutical solutions, the nutraceuticals segment is witnessing significant growth. This is especially evident in markets like North America, Europe, and Asia-Pacific, where consumers are seeking products that support their overall well-being without the side effects typically associated with prescription medications. As more people become health-conscious, particularly with an aging population in many regions, the demand for nattokinase as part of daily health regimens is expected to continue to rise, further establishing nutraceuticals as a leading application of nattokinase..

The powder form segment in the nattokinase market is projected to have a dominant share.

Powdered nattokinase is preferred by both manufacturers and consumers due to its versatility, ease of formulation, and potential for incorporation into a wide range of products, including supplements, functional foods, and beverages. Powder form offers advantages in terms of shelf stability, ease of transport, and precise dosage control, making it a highly favored option for supplement manufacturers. It also allows for better bioavailability and easier mixing into health drinks or smoothies, making it convenient for consumers seeking a simple and effective way to incorporate nattokinase into their daily diet. Additionally, the increasing trend of personalized health solutions and the ability to incorporate powdered nattokinase into various formulations has contributed to its strong position in the market.

Asia Pacific is the fastest growing region in the nattokinase market.

 The region’s growing awareness of cardiovascular health, combined with the increasing adoption of traditional health practices, has led to a rise in the use of nattokinase and other natural remedies. Countries like Japan, South Korea, and China have long used nattokinase-rich foods like natto, making it a part of the daily diet for many. As the demand for natural supplements grows globally, more consumers in Asia Pacific are turning to nattokinase to manage heart health and prevent thrombotic diseases.

Moreover, the region’s strong manufacturing base for supplements and nutraceuticals, coupled with increasing healthcare spending, contributes to the rapid expansion of the nattokinase market in this area. The growing middle class in emerging markets, rising healthcare awareness, and the increasing prevalence of cardiovascular diseases further drive the demand for nattokinase in the Asia Pacific region, positioning it as a key growth driver for the global market.

Key Market Players

Japan Bio Science Laboratory Co., Ltd. (Japan)

Novozymes A/S, Part of Novonesis Group (Denmark)

Biocat GmbH (Germany)

Bioven Ingredients (India)

Eiffel Biotech (Taiwan)

Daiwa Pharmaceutical Co., Ltd. (Japan)

Sungen Bioscience Co., Ltd. (China)

Infinita Biotech Private Limited (India)

Pharmanager Ingredients (France)

Geneferm Biotechnology Co., Ltd. (Taiwan)

These market players are focusing on increasing their presence through agreements and collaborations. These companies have a strong presence in North America, Asia Pacific, Europe, South America, and Rest of the World. They also have manufacturing facilities along with strong distribution networks across these regions.

Recent Developments

• In July 2021, Sungen Bioscience applied for a patent for a production strain of nattokinase and its method of production represents a significant development that could help the company grow in the nattokinase market. By securing intellectual property rights over a unique production strain and the production process, the company can differentiate itself from competitors, ensuring exclusive access to a high-quality and potentially more efficient strain for manufacturing nattokinase.

Frequently Asked Questions (FAQ):